May 25 2020 1:11pm

Coronavirus outbreak: WHO says uncertainty in hydroxycholoroquine resulted in pause of solidarity trial

Dr. Soumiya Swaminathan, chief scientist of the World Health Organization (WHO), explained on Monday that the hydroxychloroquine “arm” of the COVID-19 treatment Solidarity Trial was paused for enrollment due to the uncertainty surrounding the drug after a study published showed a potential higher mortality rate among COVID-19 patients taking the drug. She said the measures are temporary in order to examine published and unpublished studies on the drug.

Responsive site?

Video Home